NAOV
NanoVibronix
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About NAOV
Nanovibronix, Inc.
A noninvasive biological response-activating devices manufacturer
Healthcare Equipment and Supplies
10/20/2003
11/02/2017
NASDAQ Stock Exchange
31
12-31
Common stock
969 Pruitt Ave, Tyler, Texas 77569
--
NanoVibronix, Inc., was established as a Delaware corporation on October 20, 2003. The company is a medical device company focused on selling non-bioactive devices that allow patients to perform wound healing and pain treatment at home without the help of medical professionals. The company's wound guards, pain guards, and UroShield products are supported by a new technology that is related to ultrasonic transmission through surface sound waves. The Company's Nano Vibronix NPWT utilizes open sewer wound technology while seeking technologies that accelerate wound healing.
Company Financials
EPS
NAOV has released its 2023 Q3 earnings. EPS was reported at -0.42, versus the expected 0.00, missing expectations. The chart below visualizes how NAOV has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
NAOV has released its 2024 Q4 earnings report, with revenue of 444.00K, reflecting a YoY change of -62.28%, and net profit of -1.43M, showing a YoY change of -76.01%. The Sankey diagram below clearly presents NAOV’s revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
